First human test of lassa fever pill shows promise for safety
NCT ID NCT05735249
First seen May 03, 2026 · Last updated May 07, 2026 · Updated 1 time
Summary
This early-stage study tested an experimental oral drug, ARN-75039, in 94 healthy adults to see if it is safe and how the body processes it. The drug is being developed to treat Lassa fever, a serious viral illness. Participants received either the drug or a placebo, and researchers monitored for side effects and measured drug levels in the blood. The results will help decide if further testing in patients is warranted.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULT PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Spaulding Clinical, LLC
West Bend, Wisconsin, 53095, United States
Conditions
Explore the condition pages connected to this study.